These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 2093953

  • 21. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC.
    Clin Infect Dis; 2007 Nov 01; 45(9):1221-9. PubMed ID: 17918088
    [Abstract] [Full Text] [Related]

  • 22. Prevalence of markers of hepatitis B in the adult German population.
    Jilg W, Hottenträger B, Weinberger K, Schlottmann K, Frick E, Holstege A, Schölmerich J, Palitzsch KD.
    J Med Virol; 2001 Feb 01; 63(2):96-102. PubMed ID: 11170044
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Prevalence of occult hepatitis B virus infection in a general adult population in Korea.
    Song EY, Yun YM, Park MH, Seo DH.
    Intervirology; 2009 Feb 01; 52(2):57-62. PubMed ID: 19401629
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA, Ullah Z, Salamat N, Ayub M, Ghani E.
    Transfusion; 2007 Jan 01; 47(1):74-9. PubMed ID: 17207233
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Isolated core antibody hepatitis B in sub-Saharan African immigrants.
    Gibney KB, Torresi J, Lemoh C, Biggs BA.
    J Med Virol; 2008 Sep 01; 80(9):1565-9. PubMed ID: 18649341
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Prevalence of markers of hepatitis B virus infection in various countries: a WHO collaborative study.
    Sobĕslavský O.
    Bull World Health Organ; 1980 Sep 01; 58(4):621-8. PubMed ID: 6969134
    [Abstract] [Full Text] [Related]

  • 34. Persistence of hepatitis B and hepatitis C viral genomes in primary liver cancers from HBsAg-negative patients: a study of a low-endemic area.
    Paterlini P, Driss F, Nalpas B, Pisi E, Franco D, Berthelot P, Bréchot C.
    Hepatology; 1993 Jan 01; 17(1):20-9. PubMed ID: 8380790
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P, Mirabet V, Alvarez M, Vila E, Quiles F, Villalba JV, Montoro JA, Soler MA, Roig RJ.
    Transpl Infect Dis; 2008 Dec 01; 10(6):391-5. PubMed ID: 18665905
    [Abstract] [Full Text] [Related]

  • 40. The decline of hepatitis B viral infection in South-Western Saudi Arabia.
    Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM.
    Saudi Med J; 2003 Sep 01; 24(9):991-5. PubMed ID: 12973485
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.